Mike DiStefano

Assistant Professor @CUPharmacy | Researching health technology assessment, value assessment, pharma policy, and ethics.

[Mike DiStefano @DiStefano_MJ]

The market for compounded GLP-1s for weight loss exploded in the past few years due to high demand and shortages of drugs like Ozempic and Wegovy. In a recent paper, we describe the availability of these compounded products in Colorado. Link below! @CUPharmacy @KavitaNair70

[Josh Balk @joshbalk]

The pork industry lost with voters. Lost at the Supreme Court. So they turned to Congress—and got the "Save Our Bacon" Act buried in the House Farm Bill. It's the biggest rollback of animal welfare protections in U.S. history. A thread. 🧵

[Mike DiStefano @DiStefano_MJ]

@Mets @HowieRose .@HowieRose You're a legend. For me, indelibly associated with the Mets.

[Mike DiStefano @DiStefano_MJ]

@Jolly_Olive I'm still buzzing. Maybe the strangest and most intense Diaz half-inning I've seen. Elite work by Acuna as well.

[Mike DiStefano @DiStefano_MJ]

@patrickc Durability of treatment effect complicates this as well.

[NIHCM @NIHCMfoundation]

Congratulations to Michael DiStefano, Kavita Nair, Gina Moore, and Joseph Saseen on being selected for the 2025 cohort of #NIHCM Research Grantees!

Read more in the release: https://t.co/h3Vy1cluiB | #NIHCMGrants2025

[Mike DiStefano @DiStefano_MJ]

@joeymattingly These guys are unreal

[Mike DiStefano @DiStefano_MJ]

@leah_pierson Congrats!

[Kelly Anderson @KellyAnders0n]

Led by Antal Zemplenyi, our latest study explores how innovative payment models can improve value-based spending by linking rebates to health outcomes, using a case study of severe sickle cell disease (SCD). https://t.co/u4XmgQAXMN
@brootmcq @DiStefano_MJ

[BSPH / HPM @BSPH_HPM]

Meet the panelists for @JohnsHopkinsSPH's International Conference on Drug Pricing and Affordability:

Panel 1
Diego Ocampo from @GrupoNeolpharma
@profyadav from Council of Foreign Relations
Katherine .E. Bliss from @CSISHealth

(See more in replies.)

[Mike DiStefano @DiStefano_MJ]

https://t.co/nMEzgeahVi

[Mike DiStefano @DiStefano_MJ]

Another paper published today in @JAMAHealthForum on the market for compounded GLP-1 products for weight loss. The paper nicely complements ours (links below) by looking more at online suppliers vs. brick-and-mortar clinics and spas.

[Mike DiStefano @DiStefano_MJ]

https://t.co/C4lgDcgiCP

[Mike DiStefano @DiStefano_MJ]

We identified 93 businesses across nearly 200 clinic and med spa locations in Colorado who were advertising compounded GLP-1 products online for weight loss. Find much more here, including background on the practice of compounding: https://t.co/JWOFETyKP7 @COBioethics

[Mike DiStefano @DiStefano_MJ]

The market for compounded GLP-1s for weight loss exploded in the past few years due to high demand and shortages of drugs like Ozempic and Wegovy. In a recent paper, we describe the availability of these compounded products in Colorado. Link below! @CUPharmacy @KavitaNair70

[Kelly Anderson @KellyAnders0n]

🚨Our latest research is now online in @JAMA_current. We measure the effect of community pharmacy closures on anticonvulsant use in Colorado and find significant reductions in fills and days' supply post-closure. @joeymattingly @DiStefano_MJ @CUPharmacy

[Mike DiStefano @DiStefano_MJ]

@AnthonyDiComo Would appreciate if you could write something on this... what are the criteria for selection, what are the tradeoffs among different defensive metrics, etc? Decision seems bizarre.

[Mike DiStefano @DiStefano_MJ]

@Jolly_Olive That was glorious. Absolutely must lock this down.

[Mike DiStefano @DiStefano_MJ]

@ejprinting @AnthonyDiComo Just checked, yep. Must have stepped away. That's the worst one!

[Mike DiStefano @DiStefano_MJ]

If you're at the @AmerSocBioHum conference, consider attending our Saturday session on the ethics of weight loss and GLP-1 medications. I'll be presenting on the market for compounded GLP-1 products! @COBioethics @bermaninstitute